表紙
市場調査レポート

米国の血液検査・フローサイトメトリー検査市場:病院、民間検査所、ポイントオブケア(POC)検査所

2016-2020 Hematology and Flow Cytometry Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

発行 Venture Planning Group 商品コード 305189
出版日 ページ情報 英文 306 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。

Local License: 同一事業所内

Back to Top
米国の血液検査・フローサイトメトリー検査市場:病院、民間検査所、ポイントオブケア(POC)検査所 2016-2020 Hematology and Flow Cytometry Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations
出版日: ページ情報: 英文 306 Pages
概要

当レポートでは、米国の血液検査・フローサイトメトリー検査市場について調査分析し、現在のサプライヤーと潜在的な市場参入企業に焦点を当てて、ビジネス・技術動向、市場シェア推計、検査件数の予測、装置の設置、主要分析装置の機能比較、主要企業のプロファイル、特定の製品とマーケティング機会などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 世界市場と技術の概要

  • 定期的/特殊な血液検査
    • イントロダクション
    • CBC(全血球計算)分析
    • 白血球分析
    • 網状赤血球
    • 白血球機能検査
    • 赤血球沈降速度
    • 赤血球分析
    • DPG
    • 赤血球変形能
    • 好中球機能検査
    • 精液解析
    • 骨髄解析
    • 尿検査
  • フローサイトメトリーの応用分野
    • 細胞表面マーカー
    • DNA含有量分析
    • RNA含有量分析
    • 化学療法モニタリング
    • 細胞周期分析
    • 染色体分析
    • 胎児細胞分析
    • HLA型測定
    • 微生物学
    • タンパク質含有量分析
    • マルチパラメーター分析
    • その他の応用分野
  • 装置レビュー
  • 血液分析装置の現在の市場ニーズと将来の需要
  • 試薬とコントロール
  • 現在/新興の技術
    • IT
    • オートメーション、ロボット工学
    • レーザー
    • 人工知能
    • モノクローナル抗体
    • 分子診断
    • マイクロドロップ技術

第3章 米国

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 分散化検査の論理的根拠
  • 市場規模・成長率、主要サプライヤーの装置設置・設置ベース・売上高・市場シェア

第4章 主な製品開発の機会

  • 装置
  • 試薬キットと検査システム/パネル
  • IT
  • 補助製品

第5章 分散型検査製品の設計基準

第6章 代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 流通業者のタイプ
    • 市場区分要因

第7章 潜在的な市場参入障壁とリスク

  • 市場の成熟
  • 費用抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

第8章 競合企業の評価

  • Abbott
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • CellaVision
  • 堀場製作所
  • Iris
  • 日本光電
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • シスメックス

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPHFC17429

Summary

This comprehensive report contains 306 pages, 59 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and point-of-care/POC markets during the next five years. The report explores business and technological trends in the US hematology and flow cytometry markets; provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.

The report provides five-year volume and sales forecasts for over 40 hematology and flow cytometry procedures performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers.

Strategic Recommendations

- New product development opportunities with significant market appeal. Alternative market penetration strategies. Potential market entry barriers and risks.

Hematology Tests

CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.

Flow Cytometry Tests

Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.

Sales and Market Share Analysis

- Sales and market shares of major instrument and reagent suppliers.

Market Segmentation Analysis

- Sales and market share estimates for leading suppliers of hematology and flow cytometry products. Test and sales forecasts for over 40 procedures, by individual test and market segment:

Centralized Testing

- Hospitals Commercial/Private Laboratories

POC/Decentralized Testing

- Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers

Current and Emerging Products

- Analysis of current and emerging hematology and flow cytometry tests. Reagent and instrument sales forecasts by market segment. Instrument placements and installed base by manufacturer and model. Sales and market shares of reagent and instrument suppliers.

Technology Review

- Assessment of current and emerging technologies, and their potential market applications. Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Strategies

- Extensive strategic profiles of major suppliers and emerging market entrants.

- The companies analyzed in the report include:

   - Abbott    - Agilent Technologies    - Beckman Coulter/Danaher    - Becton Dickinson    - Bio-Rad    - CellaVision    - Horiba    - Iris Diagnostics/Danaher    - Nihon Kohden    - Ortho-Clinical Diagnostics    - Roche    - Siemens    - Sysmex

Contains 306 pages and 59 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

A. Major Routine and Special Hematology Tests

  • 1. Introduction
  • 2. CBC Analysis
    • a. Hemoglobin Concentration
    • b. Hematocrit Determination
    • c. Red Blood Cell Count
    • d. Red Cell Indices
      • MCV
      • RDW
      • MCHC
      • CHCM
      • HDW
      • MCH
    • e. Red Cell Size Histograms
    • f. Platelets
      • Platelet Count
      • Platelet Size/MPV
      • PDW
      • Automated Systems
    • g. Reticulocytes
  • 3. White Blood Cell Analysis
    • a. WBC Count
    • b. Five-Partial Differential Major Suppliers
      • Abbott
      • Beckman Coulter/Danaher
      • Siemens
      • Sysmex
    • c. Pattern Recognition Systems
      • IRIS
    • d. Comparison of Major Differential Analyzers
  • 4. Reticulocytes
  • 5. Platelet Function Tests
  • 6. Erythrocyte Sedimentation Rate/CRP
  • 7. Red Cell Analysis
  • 8. 2, 3 DPG
  • 9. Red Cell Deformability
  • 10. Neutrophil Function Tests
  • 11. Semen Analysis
  • 12. Bone Marrow Analysis
  • 13. Urinalysis

B. Major Flow Cytometry Applications

  • 1. Cell Surface Markers
    • a. Lymphocyte Subclassification CD4/CD8/CD34
      • Instrumentation and Reagent Test Kits
        • BD
        • Beckman Coulter/Danaher
        • T Cells Diagnostics
    • b. Other Cell Markers
  • 2. DNA Content Analysis
  • 3. RNA Content Analysis
  • 4. Chemotherapy Monitoring
  • 5. Cell Cycle Analysis
  • 6. Chromosome Analysis
  • 7. Fetal Cell Analysis
  • 8. HLA Typing
  • 9. Microbiology
  • 10. Protein Content Analysis
  • 11. Multiparameter Analysis
  • 12. Other Applications

C. Instrumentation Review

  • 1. Hematology Analyzers
    • a. Overview
      • Electrical Aperture-Impedance Analyzers
      • Light Scatter Analyzers
    • b. System Review
      • Abbott
      • Beckman Coulter/Danaher
      • Biocode Hycel
      • CellaVision
      • Drew-Scientific
      • Horiba
      • Medica
      • Menarini
      • Nihon Kohden
      • Siemens
      • Sysmex
  • 2. Flow Cytometers
    • a. Introduction
    • b. System Overview
      • Becton Dickinson
      • Beckman Coulter/Danaher
  • 3. Platelet Aggregometers
  • 4. Sedimentation Rate Analyzers
    • Diesse Ves Matic
    • Polymedco

D. Current Market Needs and Future Demand For Hematology Analyzers

E. Reagents and Controls

F. Current and Emerging Technologies

  • 1. Information Technologies
  • 2. Automation and Robotics
  • 3. Lasers
  • 4. Artificial Intelligence
  • 5. Monoclonal Antibodies
  • 6. Molecular Diagnostics
  • 7. Microdrop Technology

III. U.S.A.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Rationale for Testing Decentralization
    • 1. Overview
    • 2. Regulatory Trends
    • 3. Economic Trends
    • 4. Demographic Trends
    • 5. Technological Trends
    • 6. Social Trends
    • 7. Quality of Care
    • 8. Defensive Medicine
    • 9. Quality Control Issues
  • E. Market Size, Growth and Major Suppliers'Instrument Placements, Installed Base, Sales and Market Shares

IV. Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/Panels
  • C. Information Technology
  • D. Auxiliary Products

V. Design Criteria for Decentralized Testing Products

VI. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for the Decentralized Testing Markets
    • 1. Four Marketing Approaches
    • 2. Product Complexity Factor
    • 3. Customer Preference Factor
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation Factor

VII. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VIII. Competitive Assessments

  • Abbott
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • CellaVision
  • Horiba
  • Iris
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Sysmex

List of Tables

  • Summary Table I: U.S., All Market Segments, Total Hematology and Flow Cytometry Specimen Volume Forecast
  • Summary Table II: U.S., All Market Segments, Total Hematology and Flow Cytometry Test Volume Forecast
  • Summary Table III: U.S., All Market Segments, Total Hematology and Flow Cytometry Market Forecast
  • U.S., Laboratories Performing Hematology/Flow Cytometry Testing By Market Segment
  • U.S., Hospital Laboratories Performing Hematology and Flow Cytometry Tests By Bed Size
  • U.S., Commercial/Private Laboratories Performing Hematology/Flow Cytometry Tests By Annual Test Volume
  • U.S., Physician Offices/Group Practices Performing Hematology/Flow Cytometry Tests By Annual Test Volume
  • U.S., Total Routine Hematology Specimen Volume Forecast By Market Segment
  • U.S., Total Flow Cytometry and Special Hematology Specimen Volume Forecast By Market Segment
  • U.S., Hospital Laboratories, Hematology And Flow Cytometry Specimen Volume Forecast
  • U.S., Physician Offices/Group Practices, Hematology And Flow Cytometry Specimen Volume Forecast
  • U.S., Commercial/Private Laboratories, Hematology and Flow Cytometry Specimen Volume Forecast
  • U.S., Total Routine Hematology Test Volume Forecast By Market Segment
  • U.S., Total Flow Cytometry and Special Hematology Test Volume Forecast By Market Segment
  • U.S., All Market Segments, Total Routine Hematology Test Volume Forecast
  • U.S., Hospital Laboratories, Routine Hematology Test Volume Forecast
  • U.S., Commercial/Private Laboratories, Routine Hematology Test Volume Forecast
  • U.S., Physician Office Laboratories, Routine Hematology Test Volume Forecast
  • U.S., All Market Segments, Flow Cytometry and Special Hematology Test Volume Forecast
  • U.S., Hospital Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
  • U.S., Commercial/Private Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
  • U.S., Physician Office Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
  • U.S.A., Ancillary Hospital Locations Estimated Number U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Routine Hematology Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Hematology Reagent Market Forecast
  • U.S.A., Hospital Operating and Recovery Suites Routine Hematology Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Hematology Reagent Market Forecast
  • U.S.A., Hospital ICUs/CCUs Routine Hemagology Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Hematology Reagent Market Forecast
  • U.S.A., Cancer Clinics Routine Hematology/Flow Cytometry Test Volume Forecast
  • U.S.A., Cancer Clinics Hematology and Flow Cytometry Reagent Market Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Routine Hematology Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Hematology Reagent Market Forecast
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Routine Hematology Test Volume Forecast
  • U.S.A., Surgery Centers Hematology Consumable Market Forecast
  • U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
  • U.S.A., Nursing Homes Routine Hematology Test Volume Forecast
  • U.S.A., Nursing Homes Hematology Reagent Market Forecast
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Routine Hematology Test Volume Forecast
  • U.S.A., Birth Centers Hematology Reagent Market Forecast
  • U.S., Major Hematology Analyzers, Estimated Placements and Installed Base
  • U.S., Major Flow Cytometers, Estimated Placements and Installed Base
  • U.S., Total Hematology Market By Market Segment Forecast
  • U.S., Hematology Instrument Market By Markets Segment Forecast
  • U.S., Hematology Consumable Market By Market Segment Forecast
  • U.S., Total Flow Cytometry Market Forecast By Market Segment
  • U.S., Flow Cytometry Consumable Market Forecast By Market Segment
  • U.S., Flow Cytometry Instrument Market Forecast By Market Segment
  • U.S., Total Hematology Market By Major Supplier
  • U.S., Hematology Instrument Market By Major Supplier
  • U.S., Hematology Consumable Market By Major Supplier
  • U.S., Total Flow Cytometry Market By Major Supplier
  • U.S., Total Flow Cytometry Consumable Market By Major Supplier
  • U.S., Total Flow Cytometry Instrument Market By Major Supplier
Back to Top